Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 551

1.

With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.

Lim CC, van Gaal WJ, Testa L, Cuculi F, Arnold JR, Karamitsos T, Francis JM, Petersen SE, Digby JE, Westaby S, Antoniades C, Kharbanda RK, Burrell LM, Neubauer S, Banning AP.

J Am Coll Cardiol. 2011 Feb 8;57(6):653-61. doi: 10.1016/j.jacc.2010.07.058.

2.

Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.

Vranckx P, Farooq V, Garg S, Van Es GA, Silber S, Windecker S, Stone GW, Serruys PW.

Heart. 2012 Oct;98(19):1424-30. doi: 10.1136/heartjnl-2012-302267. Epub 2012 Jul 21.

PMID:
22821273
3.

New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions?

Locca D, Bucciarelli-Ducci C, Ferrante G, La Manna A, Keenan NG, Grasso A, Barlis P, Del Furia F, Prasad SK, Kaski JC, Pennell DJ, Di Mario C.

JACC Cardiovasc Interv. 2010 Sep;3(9):950-8. doi: 10.1016/j.jcin.2010.06.015.

4.

[Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].

Plak M, Orliński L, Łobos M, Ciesielczyk M, Wlazeł RN, Paradowski MT.

Pol Merkur Lekarski. 2010 Jun;28(168):444-9. Polish.

PMID:
20642101
5.

Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.

Di Chiara A, Dall'Armellina E, Badano LP, Meduri S, Pezzutto N, Fioretti PM.

J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):587-92. doi: 10.2459/JCM.0b013e3283383153.

PMID:
20588136
6.

Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting.

La Vecchia L, Bedogni F, Finocchi G, Mezzena G, Martini M, Sartori M, Castellani A, Soffiati G, Vincenzi M.

Coron Artery Dis. 1996 Jul;7(7):535-40.

PMID:
8913672
7.

Impact of the troponin standard on the prevalence of acute myocardial infarction.

Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL.

Am Heart J. 2003 Sep;146(3):446-52.

PMID:
12947361
8.
9.

Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.

Hueb W, Gersh BJ, Alves da Costa LM, Costa Oikawa FT, Vieira de Melo RM, Rezende PC, Garzillo CL, Lima EG, Nomura CH, Villa AV, Hueb AC, Cassaro Strunz CM, Favarato D, Takiuti ME, de Albuquerque CP, Ribeiro da Silva EE, Franchini Ramires JA, Kalil Filho R.

Ann Thorac Surg. 2016 Jun;101(6):2202-8. doi: 10.1016/j.athoracsur.2015.11.034. Epub 2016 Feb 22.

PMID:
26912303
12.

A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery.

Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, Lee-Lewandrowski E.

J Am Coll Cardiol. 2002 May 1;39(9):1518-23.

13.
14.

Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction.

Husser O, Bodi V, Sanchis J, Nunez J, Mainar L, Rumiz E, Lopez-Lereu MP, Monmeneu JV, Forteza MJ, Oltra R, Riegger GA, Chorro FJ, Llacer A.

Thromb Res. 2009 Nov;124(5):592-600. doi: 10.1016/j.thromres.2009.05.015. Epub 2009 Jun 21.

PMID:
19540571
15.
16.

Significant elevation of biomarkers of myocardial necrosis after coronary artery bypass grafting without myocardial infarction established assessed by cardiac magnetic resonance.

da Costa LM, Hueb W, Nomura CH, Hueb AC, Villa AV, Oikawa FT, Vieira de Melo RM, Rezende PC, Segre CA, Garzillo CL, Lima EG, Ramires JA, Kalil Filho R.

Medicine (Baltimore). 2017 Feb;96(6):e6053. doi: 10.1097/MD.0000000000006053.

17.

Myocardial injury following coronary artery surgery versus angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging.

van Gaal WJ, Arnold JR, Testa L, Karamitsos T, Lim CC, Ponnuthurai FA, Petersen S, Francis JM, Selvanayagam J, Sayeed R, West N, Westaby S, Neubauer S, Banning AP.

EuroIntervention. 2011 Jan;6(6):703-10. doi: 10.4244/EIJV6I6A119.

18.

Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.

Niccoli G, Sgueglia GA, Latib A, Crea F, Colombo A; CACTUS Study Group.

Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E37-44. doi: 10.1002/ccd.25102. Epub 2013 Aug 5.

PMID:
23813627
19.

The prognosis of periprocedural myocardial infarction after percutaneous coronary interventions.

Zimarino M, Affinito V.

Cardiovasc Revasc Med. 2013 Jan-Feb;14(1):32-6. doi: 10.1016/j.carrev.2012.10.006. Epub 2012 Nov 17. Review.

PMID:
23164601
20.

Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).

Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, Reilly JP, Zoghbi G, Holper E, Stone GW; Society for Cardiovascular Angiography and Interventions.

Catheter Cardiovasc Interv. 2014 Jan 1;83(1):27-36. doi: 10.1002/ccd.25135. Epub 2013 Oct 16.

PMID:
23894025

Supplemental Content

Support Center